US appeals court reinstates pause on generic version of Novartis’ Entresto
By Blake Brittain WASHINGTON -Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis’ blockbuster heart-failure drug Entresto. The U.S. Court of Appeals for the Federal Circuit ordered MSN not to launch its drug while it considers Novartis’ request for …
US appeals court reinstates pause on generic version of Novartis’ Entresto Read More »










